Panama vs Serbia: 10_Insured export credit exposures, short term
Panama
4.57 billion BU
in 2025
Serbia
5.46 billion BU
in 2025
Panama rank
63rd
Serbia rank
60th
10_Insured export credit exposures, short term over time
- Panama
- Serbia
How they compare
Serbia currently reports 5.46 billion BU against 4.57 billion BU in Panama, a difference of 887.00 million BU.
That makes Serbia's figure about 1.2 times Panama's.
The two have swapped places 1 time across 21 shared years of data; in 2005 it was Panama ahead.
Panama ranks 63rd and Serbia ranks 60th of 210 countries.
Across the 3 decades both report, Panama averaged higher in 2 and Serbia in 1.
Head to head by decade
| Decade | Panama | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 650.80 million BU | 125.80 million BU | 525.00 million BU | Panama |
| 2010s | 2.12 billion BU | 1.49 billion BU | 629.20 million BU | Panama |
| 2020s | 3.82 billion BU | 4.75 billion BU | 938.17 million BU | Serbia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher 10_insured export credit exposures, short term, Panama or Serbia?
- Serbia, at 5.46 billion BU against 4.57 billion BU in Panama as of 2025.
- What is the difference in 10_insured export credit exposures, short term between Panama and Serbia?
- 887.00 million BU, with Serbia ahead.
- How many years of comparable data are there for Panama and Serbia?
- 21 years are reported by both, from 2005 to 2025.
- How do Panama and Serbia rank globally for 10_insured export credit exposures, short term?
- Panama ranks 63rd and Serbia ranks 60th of 210 countries.
- Where does this data come from?
- BIS, published as 10_Insured export credit exposures, short term (BU). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
ST refers to insured export credits with credit terms up to and including 12 months, except for transactions involving an insured manufacturing (pre-credit) risk with a risk period of more than 12 months, which are classified as medium/long-term (MLT).